RF wins 12 Healthcare projects in China

April 15, 2009

RF has won 12 Healthcare projects during the first three months of 2009 in China. The new China wins expand Ruder Finn’s already impressive client roster in Asia Pacific, which includes Novartis, MSD, Parkway Healthcare and Elsevier, among others.

New clients include Astellas Pharma, AstraZeneca, Mead Johnson, Merck Sharp & Dohme (MSD), Roche, Wyeth, Sandoz and Schering Plough Pharmaceuticals. The projects range from a corporate positioning retainer to media training, product communication to media outreach and also event management.

RF has more than 10 years experience and expertise in healthcare communications in China and has established a strong reputation in the pharmaceutical industry.

In China, prescription drugs face a lot of restrictions as Chinese law does not allow advertising or the mention of brand names in promotions. In such an environment, PR becomes an important tool to educate patients about medical conditions and treatment.